Middle income vs Norway: Cause of death, by non-communicable diseases, ages 15-59
Middle income
52.6%
in 2021
Norway
75.6%
in 2021
Middle income rank
20th
Norway rank
22nd
Cause of death, by non-communicable diseases, ages 15-59 over time
- Middle income
- Norway
How they compare
Norway currently reports 75.6% against 52.6% in Middle income, a difference of 23.0%.
That makes Norway's figure about 1.4 times Middle income's.
Across all 6 years both countries report, Norway has been ahead every year.
Middle income ranks 20th and Norway ranks 22nd of 47 groups.
Norway has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Middle income | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 50.4% | 78.8% | 28.4% | Norway |
| 2010s | 60.3% | 78.7% | 18.5% | Norway |
| 2020s | 55.8% | 76.6% | 20.8% | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, Middle income or Norway?
- Norway, at 75.6% against 52.6% in Middle income as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59 between Middle income and Norway?
- 23.0%, with Norway ahead.
- How many years of comparable data are there for Middle income and Norway?
- 6 years are reported by both, from 2000 to 2021.
- How do Middle income and Norway rank globally for cause of death, by non-communicable diseases, ages 15-59?
- Middle income ranks 20th and Norway ranks 22nd of 47 groups.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59 (% of total deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 15-59 due to non-communicable diseases divided by number of all deaths ages 15-59 expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.